CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host a live audio webcast of its discussion of the Company’s clinical programs and pipeline at the ASH annual meeting on Monday, December 8, 2014, at 12:30 p.m. PT (3:30 p.m. ET).
Help employers find you! Check out all the jobs and post your resume.
